8 Results for "

onset seizures

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "onset seizures" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-B1752
CAS No.: 80373-22-4
Synonyms: LY 171555; (-)-LY 141865
Quinpirole (LY 171555; (-)-LY 141865) is a D2/D3 dopamine receptor agonist and a CaV1.3 calcium channel modulator. Quinpirole normalizes dendritic spine density in dopamine-depleted striatum, upregulates the protein expression of BCL2 and GluR2, downregulates the protein expression of BAX, and delays the onset of seizures. Quinpirole enhances learning and memory, inhibits neuronal apoptosis (apoptosis), and induces anxiety-like, stereotyped, and compulsive behaviors. Quinpirole disrupts prepulse inhibition in rhesus monkeys, enhances the activity of paraventricular thalamic neurons to promote recovery from Isoflurane anesthesia, and alters the composition of the gut microbiota in rats. Quinpirole can be used in research related to dyskinesia, pain, epilepsy, and neurological disorders including anxiety disorder, obsessive-compulsive disorder, and schizophrenia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108506
CAS No.: 29331-92-8
Purity:  99.77%
Synonyms: BIA 2-005; GP 47779
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Licarbazepine (BIA 2-005; GP 47779) is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects .
loading...
    loading...
Cat. No.: HY-Y0378
CAS No.: 328-38-1
Synonyms: (R)-Leucine
D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
loading...
    loading...
Cat. No.: HY-Y0378S
CAS No.: 271247-12-2
Synonyms: (R)-Leucine-d10
D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
loading...
    loading...
Cat. No.: HY-121872
CAS No.: 222315-88-0
Purity:  ≥95.0%
Research Areas:  

Neurological Disease

DP-b99 is a blood-brain barrier-permeable inhibitor of CYP2C9 and MMP-9, with a Ki value of 4.655 μM against CYP2C9. DP-b99 inhibits CYP2C9 via apparent non-competitive inhibition, mainly chelates pathological Zn 2+ in the membrane environment, attenuates the elevation of intracellular Zn 2+ and Ca 2+ levels, delays seizure onset and reduces seizure severity, and also prevents MMP-9-dependent dendritic spine remodeling, β-dystroglycan cleavage and gelatinase activity. DP-b99 can be used in the research of acute ischemic stroke, epileptogenesis and stroke .
loading...
    loading...
Cat. No.: HY-108506R
CAS No.: 29331-92-8
Synonyms: BIA 2-005 (Standard); GP 47779 (Standard)
Research Areas:  

Neurological Disease

Licarbazepine (Standard) is the analytical standard of Licarbazepine. This product is intended for research and analytical applications. Licarbazepine (BIA 2-005; GP 47779) is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects .
loading...
    loading...
Cat. No.: HY-129718
CAS No.: 71009-17-1
Target:  

Drug Metabolite

Research Areas:  

Neurological Disease

Nafimidone alcohol is the major metabolic of Nafimidone in plasma and urine. Nafimidone alcohol is promising for research of onset seizures .
loading...
    loading...
Cat. No.: HY-Y0378R
CAS No.: 328-38-1
Synonyms: (R)-Leucine (Standard)
D-Leucine (Standard) is the analytical standard of D-Leucine. This product is intended for research and analytical applications. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
loading...
    loading...